Corrigendum to "CEACAM1 specifically suppresses B cell receptor signaling-mediated activation"

Affiliations

• ¹ Department of Gastroenterology, Graduate School of Medical Science, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
• ² Department of Advanced Therapeutics for GI Diseases, Graduate School of Medical Science, TMDU, Tokyo, Japan.
• ³ Department of Gastroenterology, Graduate School of Medical Science, Tokyo Medical and Dental University (TMDU), Tokyo, Japan; Faculty of Medicine, Imperial College London, London, UK.
• ⁴ Department of Gastroenterology, Graduate School of Medical Science, Tokyo Medical and Dental University (TMDU), Tokyo, Japan; Department of Advanced Therapeutics for GI Diseases, Graduate School of Medical Science, TMDU, Tokyo, Japan.
• ⁵ Department of Immunology, Medical Research Institute (MRI), TMDU, Tokyo, Japan.
• ⁶ Department of Immune Regulation, Graduate School of Medical Science, TMDU, Tokyo, Japan.
• ⁷ Department of Gastroenterology, Graduate School of Medical Science, Tokyo Medical and Dental University (TMDU), Tokyo, Japan; Advanced Research Institute, TMDU, Tokyo, Japan.
• ⁸ Gastroenterology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁹ Department of Advanced Therapeutics for GI Diseases, Graduate School of Medical Science, TMDU, Tokyo, Japan. Electronic address: tnagaishi.gast@tmd.ac.jp.